DHGWA
ABBV icon

Dixon Hughes Goodman Wealth Advisors’s AbbVie ABBV Stock Holding History

Dixon Hughes Goodman Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$187K Buy
1,153
+113
+11% +$16.4K 0.05% 177
2021
Q4 		$141K Buy
+1,040
New +$123K 0.05% 176

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Dixon Hughes Goodman Wealth Advisors's ABBV Position: Q1 2022 in Review

Dixon Hughes Goodman Wealth Advisors increased its AbbVie (ABBV) stake by 11% in Q1 2022, buying an estimated $16.4K and bringing the position to 1,153 shares worth $187K. The position accounts for 0.05% of the portfolio, ranked #177.

Dixon Hughes Goodman Wealth Advisors first reported a position in ABBV in Q4 2021 and has held it in 2 quarters since. 3,052 funds tracked by Wall St. Rank hold ABBV as of Q1 2022.

  • Dixon Hughes Goodman Wealth Advisors held 1,153 shares of AbbVie worth $187K as of Q1 2022.
  • Dixon Hughes Goodman Wealth Advisors bought 113 AbbVie shares in Q1 2022, an estimated $16.4K.
  • AbbVie made up 0.05% of Dixon Hughes Goodman Wealth Advisors's portfolio in Q1 2022, its #177 holding.
  • Dixon Hughes Goodman Wealth Advisors first reported a position in AbbVie in Q4 2021 and has held it in 2 quarters since.
  • 3,052 funds tracked by Wall St. Rank held AbbVie as of Q1 2022.

Based on Dixon Hughes Goodman Wealth Advisors's 13F filing for Q1 2022, filed 4 Apr 2022.